Austria - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Austria Hospital Average Length of Stay for Malignant Neoplasm of Prostate fell by 0.6% year on year. In 2019, the country was number 16 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate with 6.4 Days. South Korea lead the ranking with 15.9 Days in 2019, that is stable compared to 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand witnessed the best average annual growth at +2.2% per year, while Mexico witnessed the worst performance at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 6.40 |
| 2018 | 6.60 |
| 2017 | 6.30 |
| 2016 | 6.30 |
| 2015 | 6.80 |
Download all data from 1989 to 2019
How does Austria rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 15 |
#15
Chile
|
6.60 | 2019 | -1.5 % | -0.9 % | View data | |
| 16 |
#16
Austria
|
6.40 | 2019 | -3.0 % | -0.6 % | View data | |
| 16 |
#16
Slovenia
|
6.40 | 2019 | +1.6 % | -2.6 % | View data | |